MiMedx Signs Distribution Agreement With Medtronic
October 01, 2013 at 07:03 AM EDT
MiMedx Group, Inc. (NASDAQ: MDXG ), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has entered into a distribution agreement with Medtronic, Inc. and SpinalGraft Technologies, LLC ("SGT"), a wholly-owned subsidiary of Medtronic (NYSE:
